| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |